Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Maine Rx Negotiations With Manufacturers Continue After Court Ruling

Executive Summary

Maine will delay enrollment for its prescription drug discount program while the state Department of Human Services attempts to reach additional discount agreements with drug manufacturers.

You may also be interested in...



Supreme Court Allows Maine Rx; PhRMA Says States Will Delay Similar Plans

The Pharmaceutical Research & Manufacturers of America believes that until Maine issues regulations to implement Maine Rx, other states will wait before proceeding with similar programs

Supreme Court Allows Maine Rx; PhRMA Says States Will Delay Similar Plans

The Pharmaceutical Research & Manufacturers of America believes that until Maine issues regulations to implement Maine Rx, other states will wait before proceeding with similar programs

PhRMA v. Maine: Supreme Court Suggests HHS Should Review Maine Rx

Several Supreme Court justices appear interested in hearing HHS' opinion on whether the Maine Rx program should proceed

Related Content

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel